Home › Companies › VENTYX BIOSCIENCES INC. › 2024-2025
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and VENTYX BIOSCIENCES INC.’s Form 8-K, filed June 10, 2025 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 4, 2025: 4 items on VENTYX BIOSCIENCES INC.’s Form 8-K, filed June 10, 2025: 2 elected · 2 approved.
Significant dissent: 1 director (45.8% against); 1 say-on-pay vote (65.2% support).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore VENTYX BIOSCIENCES INC. in the interactive database Compare manager voting policies
These tallies are VENTYX BIOSCIENCES INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 10, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Somasundaram Subramaniam, M.B.A. | 17,175,776 | -- | -- | 14,517,133 | 17,997,451 | 54.2% | Elected | — |
| Elect Director: Sheila Gujrathi, M.D. | 29,409,104 | -- | -- | 2,283,805 | 17,997,451 | 93% | Elected | — |
| 2. Advisory Vote on Executive Compensation | 20,421,575 | 10,900,876 | 370,458 | -- | 17,997,451 | 65% | Approved | — |
| 3. Ratification of Appointment of Independent Registered Public Accounting Firm | 47,804,128 | 1,580,619 | 305,614 | -- | -- | 97% | Approved | — |
Source: VENTYX BIOSCIENCES INC., Form 8-K, filed with the SEC on June 10, 2025 — read the filing on EDGAR.
See voting trends for Health Care companies, 2024-2025: shareholder support by sector and by company size.
117 asset managers disclosed a vote on at least one VENTYX BIOSCIENCES INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 2 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
Description as filed by funds: To elect two Class I directors to hold office until our 2028 annual meeting of stockholders and until their respective successors are elected and qualified: Sheila Gujrathi, M.D.
VENTYX BIOSCIENCES INC.’s own tally for this item (“Elect Director: Sheila Gujrathi, M.D.”): 29,409,104 for, 2,283,805 withheld, per its Form 8-K filed June 10, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The following nominees were re-elected by the holders of our common stock to serve as our Class I directors to hold office until our 2028 annual meeting of stockholders and until their successors have been duly elected and qualified:”
Support: 93% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 36 asset managers below reported 7,796,839 for, 175,421 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,475,555 | 0 | 0 | 0 | For |
| Fidelity | 1,340,055 | 0 | 0 | 0 | For |
| BlackRock | 968,864 | 0 | 0 | 0 | For |
| Charles Schwab | 450,985 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 430,000 | 0 | 0 | 0 | For |
| JPMorgan | 273,718 | 0 | 0 | 0 | For |
| Equitable | 214,130 | 0 | 0 | 0 | For |
| TIAA | 132,656 | 0 | 0 | 0 | For |
| Lincoln Financial | 56,668 | 0 | 0 | 49,206 | Mixed |
| Invesco | 98,897 | 0 | 0 | 0 | For |
| Voya | 0 | 0 | 0 | 65,470 | Withhold |
| AIG/SunAmerica | 47,311 | 0 | 0 | 0 | For |
| AQR | 42,693 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 39,000 | 0 | 0 | 0 | For |
| Global X | 36,018 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 31,088 | Withhold |
| Northern Trust | 28,505 | 0 | 0 | 0 | For |
| Pacific Life | 28,016 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 26,957 | 0 | 0 | 0 | For |
| John Hancock | 24,081 | 0 | 0 | 0 | For |
| State Street | 0 | 0 | 0 | 21,167 | Withhold |
| Nationwide | 16,546 | 0 | 0 | 0 | For |
| Goldman Sachs | 15,753 | 0 | 0 | 0 | For |
| ProShares | 12,282 | 0 | 0 | 0 | For |
| DWS | 9,709 | 0 | 0 | 0 | For |
Showing the 25 largest of 36 asset managers. All 36 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
54.2% Majority: yes · of votes cast
Description as filed by funds: To elect two Class I directors to hold office until our 2028 annual meeting of stockholders and until their respective successors are elected and qualified: Somasundaram Subramaniam, M.B.A.
VENTYX BIOSCIENCES INC.’s own tally for this item (“Elect Director: Somasundaram Subramaniam, M.B.A.”): 17,175,776 for, 14,517,133 withheld, per its Form 8-K filed June 10, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The following nominees were re-elected by the holders of our common stock to serve as our Class I directors to hold office until our 2028 annual meeting of stockholders and until their successors have been duly elected and qualified:”
Support: 54.2% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 36 asset managers below reported 5,223,547 for, 2,748,713 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,475,555 | 0 | 0 | 0 | For |
| Fidelity | 1,340,055 | 0 | 0 | 0 | For |
| BlackRock | 0 | 0 | 0 | 968,864 | Withhold |
| Charles Schwab | 0 | 0 | 0 | 450,985 | Withhold |
| Delaware/Macquarie | 0 | 0 | 0 | 430,000 | Withhold |
| JPMorgan | 273,718 | 0 | 0 | 0 | For |
| Equitable | 0 | 0 | 0 | 214,130 | Withhold |
| TIAA | 0 | 0 | 0 | 132,656 | Withhold |
| Lincoln Financial | 104,868 | 0 | 0 | 1,006 | For |
| Invesco | 0 | 0 | 0 | 98,897 | Withhold |
| Voya | 0 | 0 | 0 | 65,470 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 47,311 | Withhold |
| AQR | 0 | 0 | 0 | 42,693 | Withhold |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 39,000 | Withhold |
| Global X | 0 | 0 | 0 | 36,018 | Withhold |
| Dimensional | 0 | 0 | 0 | 31,088 | Withhold |
| Northern Trust | 0 | 0 | 0 | 28,505 | Withhold |
| Pacific Life | 0 | 0 | 0 | 28,016 | Withhold |
| Bridge Builder Trust | 0 | 0 | 0 | 26,957 | Withhold |
| John Hancock | 0 | 0 | 0 | 24,081 | Withhold |
| State Street | 21,167 | 0 | 0 | 0 | For |
| Nationwide | 0 | 0 | 0 | 16,546 | Withhold |
| Goldman Sachs | 0 | 0 | 0 | 15,753 | Withhold |
| ProShares | 0 | 0 | 0 | 12,282 | Withhold |
| DWS | 0 | 0 | 0 | 9,709 | Withhold |
Showing the 25 largest of 36 asset managers. All 36 are in the interactive database (link above).
Combines 8 wordings of this item as funds reported it.
65% Approved · of votes cast
Prior year: 76.7% for (June 5, 2024 meeting) ▼ 11.5 pts
Description as filed by funds: To approve, on an advisory basis, the compensation of the named executive officers identified in the 2024 Summary Compensation Table in the "Executive Compensation" section of the proxy statement (the "Say-on-Pay Vote").
VENTYX BIOSCIENCES INC.’s own tally for this item (“2. Advisory Vote on Executive Compensation”): 20,421,575 for, 10,900,876 against — passed, per its Form 8-K filed June 10, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The "say-on-pay" proposal regarding the compensation of our named executive officers as described on page 18 of the Proxy Statement was approved, on an advisory basis.”
Support: 65% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,475,555 | 0 | 0 | 0 | For |
| Fidelity | 1,340,055 | 0 | 0 | 0 | For |
| BlackRock | 968,864 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 450,985 | 0 | 0 | Against |
| Delaware/Macquarie | 0 | 430,000 | 0 | 0 | Against |
| JPMorgan | 273,718 | 0 | 0 | 0 | For |
| Equitable | 214,130 | 0 | 0 | 0 | For |
| TIAA | 0 | 132,656 | 0 | 0 | Against |
| Lincoln Financial | 104,868 | 1,006 | 0 | 0 | For |
| Invesco | 0 | 98,897 | 0 | 0 | Against |
| Voya | 0 | 65,470 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 47,311 | 0 | 0 | Against |
| AQR | 0 | 42,693 | 0 | 0 | Against |
| BRIDGEWAY FUNDS INC | 0 | 39,000 | 0 | 0 | Against |
| Global X | 0 | 36,018 | 0 | 0 | Against |
| Dimensional | 0 | 31,088 | 0 | 0 | Against |
| Northern Trust | 28,505 | 0 | 0 | 0 | For |
| Pacific Life | 28,016 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 26,957 | 0 | 0 | 0 | For |
| John Hancock | 0 | 24,081 | 0 | 0 | Against |
| State Street | 21,167 | 0 | 0 | 0 | For |
| Nationwide | 16,546 | 0 | 0 | 0 | For |
| Goldman Sachs | 0 | 15,753 | 0 | 0 | Against |
| ProShares | 0 | 12,282 | 0 | 0 | Against |
| DWS | 0 | 9,709 | 0 | 0 | Against |
Fund voting reports, all 36 managers: 6,501,957 for, 1,470,303 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,874,761 | 428 | 0 | 0 | For |
| Point72 | 0 | 1,765,617 | 0 | 0 | Against |
| Vestal Point Capital, LP | 0 | 1,679,999 | 0 | 0 | Against |
| GEODE CAPITAL MANAGEMENT, LLC | 1,497,970 | 0 | 0 | 0 | For |
| Redmile Group, LLC | 0 | 1,297,042 | 0 | 0 | Against |
| State Street | 1,000,797 | 11,599 | 0 | 0 | For |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | 753,891 | 0 | 0 | Against |
| JPMorgan | 645,378 | 0 | 0 | 0 | For |
| Citadel | 590,324 | 0 | 0 | 0 | For |
| AQR | 0 | 523,919 | 0 | 0 | Against |
| Affinity Asset Advisors, LLC | 485,649 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 450,985 | 0 | 0 | Against |
| MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST | 0 | 430,000 | 0 | 0 | Against |
| Northern Trust | 418,583 | 8,289 | 0 | 0 | For |
| Qiming U.S. Ventures Management, LLC | 412,225 | 0 | 0 | 0 | For |
| TCG Crossover Management, LLC | 316,195 | 0 | 0 | 0 | For |
| ADAR1 Capital Management, LLC | 0 | 281,600 | 0 | 0 | Against |
| CIBC WORLD MARKET INC. | 0 | 272,500 | 0 | 0 | Against |
| MELLON INVESTMENTS Corp | 225,147 | 0 | 0 | 0 | For |
| Graham Capital Management, L.P. | 0 | 224,008 | 0 | 0 | Against |
| Nuveen | 0 | 168,420 | 0 | 0 | Against |
| Two Sigma | 0 | 146,767 | 0 | 0 | Against |
| T. Rowe Price | 0 | 120,483 | 0 | 0 | Against |
| Invesco | 0 | 118,765 | 0 | 0 | Against |
| HighTower Advisors, LLC | 0 | 109,271 | 0 | 0 | Against |
Institutional-manager reports, all 95 managers: 7,710,347 for, 8,929,764 against. Showing the 25 largest; every one is in the interactive database (link above).
97% Approved · of votes cast
Prior year: 99.8% for (June 5, 2024 meeting) ▼ 3.0 pts
Description as filed by funds: TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR OUR FISCAL YEAR ENDING DECEMBER 31, 2025.
VENTYX BIOSCIENCES INC.’s own tally for this item (“3. Ratification of Appointment of Independent Registered Public Accounting Firm”): 47,804,128 for, 1,580,619 against — passed, per its Form 8-K filed June 10, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025 was ratified based on the following results of voting:”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 36 asset managers below reported 7,972,260 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,475,555 | 0 | 0 | 0 | For |
| Fidelity | 1,340,055 | 0 | 0 | 0 | For |
| BlackRock | 968,864 | 0 | 0 | 0 | For |
| Charles Schwab | 450,985 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 430,000 | 0 | 0 | 0 | For |
| JPMorgan | 273,718 | 0 | 0 | 0 | For |
| Equitable | 214,130 | 0 | 0 | 0 | For |
| TIAA | 132,656 | 0 | 0 | 0 | For |
| Lincoln Financial | 105,874 | 0 | 0 | 0 | For |
| Invesco | 98,897 | 0 | 0 | 0 | For |
| Voya | 65,470 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 47,311 | 0 | 0 | 0 | For |
| AQR | 42,693 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 39,000 | 0 | 0 | 0 | For |
| Global X | 36,018 | 0 | 0 | 0 | For |
| Dimensional | 31,088 | 0 | 0 | 0 | For |
| Northern Trust | 28,505 | 0 | 0 | 0 | For |
| Pacific Life | 28,016 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 26,957 | 0 | 0 | 0 | For |
| John Hancock | 24,081 | 0 | 0 | 0 | For |
| State Street | 21,167 | 0 | 0 | 0 | For |
| Nationwide | 16,546 | 0 | 0 | 0 | For |
| Goldman Sachs | 15,753 | 0 | 0 | 0 | For |
| ProShares | 12,282 | 0 | 0 | 0 | For |
| DWS | 9,709 | 0 | 0 | 0 | For |
Showing the 25 largest of 36 asset managers. All 36 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 70,499,332 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 4.93% |
| 2 | Fidelity | 1.90% |
| 3 | BlackRock | 1.37% |
| 4 | Charles Schwab | 0.64% |
| 5 | Delaware/Macquarie | 0.61% |
| 6 | JPMorgan | 0.39% |
| 7 | Equitable | 0.30% |
| 8 | TIAA | 0.19% |
| 9 | Lincoln Financial | 0.15% |
| 10 | Invesco | 0.14% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BlackRock | 2.66% |
| 2 | Point72 | 2.50% |
| 3 | Vestal Point Capital, LP | 2.38% |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 2.12% |
| 5 | Redmile Group, LLC | 1.84% |
| 6 | State Street | 1.44% |
| 7 | Connor, Clark & Lunn Investment Management Ltd. | 1.07% |
| 8 | JPMorgan | 0.92% |
| 9 | Citadel | 0.84% |
| 10 | AQR | 0.74% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| Somasundaram Subramaniam | 5,425,425 | 7.70% | Schedule 13D, filed March 12, 2025 |
| BlackRock | 4,439,265 | 6.30% | Form 13F, quarter ended March 31, 2025 |
| Entities affiliated with Point72 Asset Management, L.P. | 4,400,325 | 6.24% | Proxy statement (DEF 14A), table as of April 10, 2025 |
| Raju Mohan | 4,387,682 | 6.22% | Schedule 13D, filed January 9, 2026 |
| Entities affiliated with Citadel Advisors LLC | 4,279,553 | 6.07% | Proxy statement (DEF 14A), table as of April 10, 2025 |
| Point72 | 4,234,804 | 6.01% | Form 13F, quarter ended March 31, 2025 |
| Affinity Healthcare Fund, LP | 4,057,105 | 5.75% | Schedule 13G, filed May 30, 2025 |
| Entities affiliated with New Science Ventures | 4,032,213 | 5.72% | Proxy statement (DEF 14A), table as of April 10, 2025 |
| Vanguard Group | 3,513,199 | 4.98% | Form 13F, quarter ended March 31, 2025 |
| Geode Capital | 1,463,103 | 2.08% | Form 13F, quarter ended March 31, 2025 |
Percentages above are of 70,499,332 shares outstanding, as reported by VENTYX BIOSCIENCES INC. on its Form 10-Q dated May 6, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At VENTYX BIOSCIENCES INC.'s shareholder meeting held June 4, 2025, in the 2024-2025 proxy season, 117 asset managers reported votes on at least one of its 4 ballot items in their SEC Form N-PX filings, covering 521 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of the named executive officers identified… — VENTYX BIOSCIENCES INC.'s filing reports the proposal as approved, with 65% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: VENTYX BIOSCIENCES INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 10, 2025.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from VENTYX BIOSCIENCES INC.’s 10-Q dated May 6, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
VENTYX BIOSCIENCES INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.
Proxy Votes Now, “VENTYX BIOSCIENCES INC. 2025 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/ventyx-biosciences-inc/2025 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.